Pharmaceutical Sciences III. (Poster discussion will take place on the terrace of the room during the Coffee Break)
Dr. Makkos, András
Department of Pharmacology and Pharmacotherapy
+36703707325
makkos.andras@med.semmelweis-univ.hu
Effect of a MicroRNA Mimic on Cardiac Gene Expression in Mice
Bence Ágg1, Zoltán V. Varga1, Anikó Görbe1, Péter Ferdinandy1
1 Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest
Szóbeli
Pharmaceutical Sciences III. (Poster discussion will take place on the terrace of the room during the Coffee Break)
English
Pharmaceutical Sciences
Background: Cardiovascular diseases are leading cause of death worldwide. Novel therapies in the field have great potential to alleviate the burden of disease in terms of both social economics and individual morbidity. MicroRNAs are great candidates of these novel approaches.
Aim: The objective of this study is to investigate the effects of a miRNA mimic on myocardial gene expression in a small animal model.
Methods: Single injection of 10 µg miRNA mimic in neutral lipid emulsion was injected intravenously into mice. Animals were sacrificed 1, 2, 4, 8 or 24 hours after treatment administration. At the time of termination, plasma and left ventricular myocardium tissue samples were collected. Total RNA was isolated from the samples, and complementary DNA library was prepared for further analysis. MiRNA and selected target mRNA expression levels were measured with qRT-PCR.
Results: 47 from 50 mice underwent successful tail vein injection and no acute side effects were observed. 1 hour after treatment, the expression of the miRNA was nearly 20-fold elevated in plasma and 8-10-fold elevated in the myocardium, however, this elevation decreased rapidly. The expression of 3 selected target mRNAs out of 5 was reduced 8 hours after injection.
Conclusions: The applied intravenous miRNA mimic was able to reach the myocardium and induce an elevation in miRNA level. The observed difference in the time frame of the induced miRNA and target mRNA changes suggests a shift in the development of changes in target gene expression. This finding can be of importance in future studies and drug development.
Semmelweis University, Doctoral School of Pharmaceutical Sciences
Anikó Görbe, MD, PhD, Péter Ferdinandy, MD, PhD, DSc, MBA
I do not give consent to the publication of my abstract on the website of the congress.
Szabad
elfogadva
szóbeli
nem rendelkezett róla
1293
12:00
12:15
Bence Ágg1, Zoltán V. Varga1, Anikó Görbe1, Péter Ferdinandy1
1 Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest